Abstract

Extracorporeal blood purification (EBP) therapies, using oXiris® haemofilter, are popular and used globally in intensive care units for management of patients with septic acute kidney injury (AKI). Herein, we present a case of an immunocompromised renal transplant recipient with sepsis and AKI who was treated with continuous renal replacement therapy (CRRT) using oXiris® haemofilter. A 45-year-old female who underwent cadaveric renal transplantation in 2015 was admitted due to septic shock secondary to Escherichia coli urinary tract infection (bacteraemia) and acute respiratory distress syndrome (ARDS). Her acute physiology and chronic health assessment score was 23, sepsis-related organ failure score was 11 and Glasgow coma scale was 15. She was intubated because of moderate ARDS and administered vasopressors due to hemodynamic instability. For immunosuppressive therapy, methylprednisolone (40 mg q12h) was administered. Antimicrobial therapies, including intravenous meropenem, linezolid, trimethoprim-sulfamethoxazole, voriconazole and oseltamivir, were administered. She exhibited metabolic acidosis and septic AKI and was classified as Kidney Disease Improving Global Outcomes stage 3. Therefore, CRRT with oXiris® haemofilter was administered at the 11th hour after admission. A full recovery of transplant renal function and diuresis was observed 7 days after admission. She was transferred to ward after 9 days and discharged after 2 weeks, without the requirement of RRT. EBP is proposed as an adjuvant therapy for sepsis and AKI. Solid organ transplant recipients with septic AKI may benefit from early usage of oXiris® haemofilter with CRRT as a novel approach for improving survival and clinical outcomes.

Keywords: Sepsis, acute kidney injury, renal replacement therapy, renal transplant recipient, extracorporeal blood purification

References

  1. Case J, Khan S, Khalid R, Khan A. Epidemiology of acute kidney injury in the intensive care unit. Crit Care Res Pract 2013;2013:479730.
  2. Bellomo R, Kellum JA, Ronco C, Wald R, Martensson J, Maiden M, et al. Acute kidney injury in sepsis. Intensive Care Med 2017;43:816-28.
  3. Honore PM, Jacobs R, Joannes-Boyau O, De Regt J, Boer W, De Waele E, et al. Septic AKI in ICU patients. diagnosis, pathophysiology, and treatment type, dosing, and timing: a comprehensive review of recent and future developments. Ann Intensive Care 2011;1:32.
  4. Monard C, Rimmelé T, Ronco C. Extracorporeal Blood Purification Therapies for Sepsis. Blood Purif 2019;47 Suppl 3:1-14.
  5. Gambro Industries. oXirisTM Instructions for use, 2015. https://www.baxter.com/healthcare-professionals/critical-care/oxiris-critical-care
  6. Imahase H, Sakamoto Y, Kusunose M, Koami H, Nishimura Y, Goto A, et al. Examination of blood filtration membrane removal ability of HMGB1. Crit Care 2012;16(Suppl 3):1-58.
  7. Turani F, Candidi F, Barchetta R, Grilli E, Belli A, Papi E, et al. Continuous renal replacement therapy with the adsorbent membrane oXiris in septic patients: a clinical experience. Crit Care 2013;17(Suppl 2):1-200.
  8. Malard B, Lambert C, Kellum JA. In vitro comparison of the adsorption of inflammatory mediators by blood purification devices. Intensive Care Med Exp 2018;6:12.
  9. Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 2016;315:801-10.
  10. Mondhe S, Reddy PV, Gundlapalli S, Hedau S, Yachha M, Kumthekar G, et al. Experience of extracorporeal therapy OXIRIS for sepsis in indian tertiary care hospital. Twentieth International Conference on Advances in Critical Care Nephrology; 2017 Mar 7-10; Manchester Grand Hyatt San Diego, California. Available from: https://www.crrtonline.com/conference/posters_2017/95%20Suhas%20Mondhe.pdf
  11. Broman ME, Bodelsson M. Analysis of Endotoxin Adsorption in Two Swedish Patients with Septic Shock. Blood Purif 2019;47:1-3.
  12. Chiu CT, Yeh YC. Blood purification in critically ill patients with sepsis and septic shock. J Emerg Crit Care Med 2018;2:77.
  13. Broman ME, Hansson F, Vincent JL, Bodelsson M. Endotoxin and cytokine reducing properties of the oXiris membrane in patients with septic shock: A randomized crossover double-blind study. PLoS One 2019;14:0220444.
  14. Shum HP, Chan KC, Kwan MC, Yan WW. Application of endotoxin and cytokine adsorption haemofilter in septic acute kidney injury due to Gram-negative bacterial infection. Hong Kong Med J 2013;19:491-7.
  15. Adamik BA, Smiechowicz JS, Zielinski SZ, Kübler AK. Use of extracorporeal endotoxin elimination therapy for septic shock. Crit Care 2013;17(Suppl 2):P66.
  16. Tan HK, Kaushik M, Tan CW, Liew ZH, Teo SH, Loo CM, et al. Augmented Adsorptive Blood Purification during Continuous Veno-Venous Haemodiafiltration in a Severe Septic, Acute Kidney Injury Patient: Use of oXiris®: A Single Centre Case Report. Blood Purif 2019;47:1-6.
  17. Schwindenhammer V, Girardot T, Chaulier K, Grégoire A, Monard C, Huriaux L, et al. oXiris® Use in Septic Shock: Experience of Two French Centres. Blood Purif 2019;47:1-7.
  18. Zhang L, Yan Tang GK, Liu S, Cai J, Chan WM, Yang Y, et al. Hemofilter with Adsorptive Capacities: Case Report Series. Blood Purif 2019;47:1-6.
  19. Turani F, Barchetta R, Falco M, Busatti S, Weltert L. Continuous Renal Replacement Therapy with the Adsorbing Filter oXiris in Septic Patients: A Case Series. Blood Purif 2019;47:1-5.
  20. Govil D, Gupta S, Srinivasan S, Patel SJ, Jagadeesh KN, Shafi M, et al. Cytokine removal in sepsis: does their levels co-relate with outcome. Kidney Int Rep 2017;2:S29.
  21. Tang GKY, Ng PY, Tsai PNW, To HMH, Leung YYN, Chan WM. oXiris in sepsis: A case series in Hong Kong. Poster presented at: 2nd Asia Pacific AKI CRRT; 2018 p. 21-24; Taipei, Taiwan.
  22. Govil D, Gupta S, Srinivasan S, Patel SJ, Jagadeesh KN, Shafi M, et al. Cytokine adsorption in sepsis: correct timing can predict the favorable outcome. Kidney Int Rep 2017;2:S29.
  23. Keles E, Fidan K, Yenicesu I, Kalkan G. Successful application of CytoSorb® hemadsorption in an immunocompromised teenager with collapsing glomerulopathy, acute respiratory distress syndrome, and sepsis. Int J Artif Organs 2019;42:765-9.

Copyright and license

Copyright © 2021 The Author(s). This is an open access article distributed under the Creative Commons Attribution License (CC BY), which permits unrestricted use, distribution, and reproduction in any medium or format, provided the original work is properly cited.

How to cite?

1.
Yeşiler Fİ, Yurtsever BM, Gedik E, Zeyneloğlu P, Haberal M. A Novel Therapeutic Approach for Renal Transplant Recipient with Septic Shock and Acute Kidney Injury: A Case Report. Turk J Intensive Care. 2021;19(2):98-104. https://doi.org/10.4274/tybd.galenos.2021.52297